Fingerprint
Dive into the research topics where Hans Frandsen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
- 3 Journal article
-
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
PIONEER 5 Investigators, 1 Jul 2019, In: The Lancet Diabetes and Endocrinology. 7, 7, p. 515-527 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
306 Citations (Scopus) -
Take Control: A randomized trial evaluating the efficacy and safety of self- versus physician-managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes
Russell-Jones, D., Dauchy, A., Delgado, E., Dimitriadis, G., Frandsen, H. A., Popescu, L., Schultes, B., Strojek, K., Bonnemaire, M., Roborel de Climens, A. & Davies, M., Jul 2019, In: Diabetes, Obesity and Metabolism. 21, 7, p. 1615-1624 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
39 Citations (Scopus) -
Altered peripheral vasodilator profile of nitroglycerin during long-term infusion of N-acetylcysteine
Boesgaard, S., Iversen, H. K., Wroblewski, H., Poulsen, H. E., Frandsen, H., Kastrup, J. & Aldershvile, J., Jan 1994, In: Journal of the American College of Cardiology. 23, 1, p. 163-9 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
28 Citations (Scopus)